Companies similar to Regeneron Pharmaceuticals (REGN)
Health Care
Regeneron Pharmaceuticals (REGN)'s closest peers include Amgen (AMGN), Bristol Myers Squibb (BMY), Lilly (Eli) (LLY), Pfizer (PFE) and Moderna (MRNA). This peer set is drawn from REGN's enriched company profile and is informational only — not financial advice.
Similar companies
-
AmgenAMGNHealth Care
A global biotechnology innovator producing biologics, monoclonal antibodies, and small molecules across oncology, cardiovascular, inflammation, and bone…
$371.58 (as of 2026-07-16) · market cap $196.8B
-
Bristol Myers SquibbBMYHealth Care
A diversified biopharmaceutical company leveraging immunotherapy, cell therapies, and small-molecule platforms to address cancer, autoimmune disease, and…
$60.51 (as of 2026-07-16) · market cap $121.8B
-
Lilly (Eli)LLYHealth Care
A global pharmaceutical powerhouse developing innovative medicines across cardiometabolic, oncology, and immunology with blockbuster GLP-1 and weight-loss…
$1,169.17 (as of 2026-07-16) · market cap $1.09T
-
PfizerPFEHealth Care
Global biopharmaceutical company discovering, developing, and manufacturing prescription medicines and vaccines across oncology, immunology, cardiovascular,…
$25.14 (as of 2026-07-16) · market cap $143.1B
-
ModernaMRNAHealth Care
Moderna is an unprofitable mRNA vaccine and therapeutic company pivoting from peak COVID revenues with a diversified pipeline facing intense competition and…
$63.15 (as of 2026-07-16) · market cap $25.1B
Not quite? Describe exactly what you want →
Peers are drawn from REGN's enriched profile (the same similarity signal the chat uses for "companies like REGN"). See the full profile: Regeneron Pharmaceuticals (REGN).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.